129 related articles for article (PubMed ID: 6337603)
1. Effect of dazoxiben, a specific inhibitor of thromboxane synthetase, on acute pulmonary responses to E. coli endotoxin in anaesthetized cats.
Ball HA; Parratt JR; Zeitlin IJ
Br J Clin Pharmacol; 1983; 15 Suppl 1(Suppl 1):127S-131S. PubMed ID: 6337603
[TBL] [Abstract][Full Text] [Related]
2. Selective inhibition of thromboxane synthesis during experimental endotoxemia in the goat: effects on pulmonary haemodynamics and lung lymph flow.
Harlan J; Winn R; Hildebrandt J; Harker L
Br J Clin Pharmacol; 1983; 15 Suppl 1(Suppl 1):123S-126S. PubMed ID: 6337602
[TBL] [Abstract][Full Text] [Related]
3. Effects of OKY-046, a selective thromboxane synthetase inhibitor, on endotoxin-induced lung injury in unanesthetized sheep.
Kubo K; Kobayashi T
Am Rev Respir Dis; 1985 Sep; 132(3):494-9. PubMed ID: 3898941
[TBL] [Abstract][Full Text] [Related]
4. Thromboxane and pulmonary hypertension following E. coli endotoxin infusion in sheep: effect of an imidazole derivative.
Watkins WD; Hüttemeier PC; Kong D; Peterson MB
Prostaglandins; 1982 Mar; 23(3):273-85. PubMed ID: 7048422
[TBL] [Abstract][Full Text] [Related]
5. The release of prostanoids during the acute pulmonary response to E. coli endotoxin in anaesthetized cats.
Coker SJ; Hughes B; Parratt JR; Rodger IW; Zeitlin IJ
Br J Pharmacol; 1983 Mar; 78(3):561-70. PubMed ID: 6340786
[TBL] [Abstract][Full Text] [Related]
6. Prevention of endotoxin-induced pulmonary hypertension in primates by the use of a selective thromboxane synthetase inhibitor, OKY 1581.
Casey LC; Fletcher JR; Zmudka MI; Ramwell PW
J Pharmacol Exp Ther; 1982 Aug; 222(2):441-6. PubMed ID: 6896528
[TBL] [Abstract][Full Text] [Related]
7. Acute arterial thrombosis in rabbits: reduced platelet accumulation after treatment with dazoxiben hydrochloride (UK 37,248-01).
Randall MJ; Wilding RI
Br J Clin Pharmacol; 1983; 15 Suppl 1(Suppl 1):49S-55S. PubMed ID: 6687429
[TBL] [Abstract][Full Text] [Related]
8. The effect of a thromboxane synthetase inhibitor, dazoxiben, and acetylsalicylic acid on platelet function and prostaglandin metabolism.
Dale J; Thaulow E; Myhre E; Parry J
Thromb Haemost; 1983 Oct; 50(3):703-6. PubMed ID: 6689091
[TBL] [Abstract][Full Text] [Related]
9. Prevention of extension of ischaemic damage following acute myocardial ischaemia by dazoxiben, a new thromboxane synthetase inhibitor.
Burke SE; Lefer AM; Smith GM; Smith JB
Br J Clin Pharmacol; 1983; 15 Suppl 1(Suppl 1):97S-101S. PubMed ID: 6681711
[TBL] [Abstract][Full Text] [Related]
10. [Experimental study on the pathophysiology of endotoxin shock as analysed by alterations in thromboxane B2 and 6-keto-PGF1 alpha levels].
Baba H
Nihon Geka Gakkai Zasshi; 1988 Jan; 89(1):6-20. PubMed ID: 3283521
[TBL] [Abstract][Full Text] [Related]
11. Modulation of arachidonic acid metabolism in endotoxic horses: comparison of flunixin meglumine, phenylbutazone, and a selective thromboxane synthetase inhibitor.
Moore JN; Hardee MM; Hardee GE
Am J Vet Res; 1986 Jan; 47(1):110-3. PubMed ID: 3080926
[TBL] [Abstract][Full Text] [Related]
12. Effects of a specific thromboxane synthetase inhibitor in equine endotoxaemia.
Semrad SD; Moore JN
Res Vet Sci; 1987 Sep; 43(2):137-42. PubMed ID: 3317581
[TBL] [Abstract][Full Text] [Related]
13. Effect of the thromboxane synthetase inhibitor UK-37,248 (dazoxiben) upon platelet aggregation, coronary artery thrombosis and vascular reactivity.
Schumacher WA; Lucchesi BR
J Pharmacol Exp Ther; 1983 Dec; 227(3):790-6. PubMed ID: 6418881
[TBL] [Abstract][Full Text] [Related]
14. Effects of thromboxane synthetase inhibition on arachidonate metabolism and platelet behaviour.
Parry MJ
Br J Clin Pharmacol; 1983; 15 Suppl 1(Suppl 1):23S-29S. PubMed ID: 6401997
[TBL] [Abstract][Full Text] [Related]
15. Use of a thromboxane synthetase inhibitor, dazoxiben, during haemodialysis.
Dodd NJ; Gordge MP; Weston MJ
Br J Clin Pharmacol; 1983; 15 Suppl 1(Suppl 1):67S-70S. PubMed ID: 6337605
[TBL] [Abstract][Full Text] [Related]
16. On the mechanism of thrombolytic action of thromboxane synthetase inhibitors.
Korbut R; Dembińska-Kieć A; Swies J; Zmuda A; Gryglewski RJ
Thromb Haemost; 1987 Oct; 58(3):827-30. PubMed ID: 3324381
[TBL] [Abstract][Full Text] [Related]
17. Haemodynamic and metabolic effects of dazoxiben at rest and during atrial pacing.
Kiff PS; Bergman G; Atkinson L; Jewitt DE; Westwick J; Kakkar VV
Br J Clin Pharmacol; 1983; 15 Suppl 1(Suppl 1):73S-77S. PubMed ID: 6681708
[TBL] [Abstract][Full Text] [Related]
18. Attenuation of the pulmonary vascular response to endotoxin by a thromboxane synthesis inhibitor (UK-38485) in unanesthetized sheep.
Henry CL; Ogletree ML; Brigham KL; Hammon JW
J Surg Res; 1991 Jan; 50(1):77-81. PubMed ID: 1987435
[TBL] [Abstract][Full Text] [Related]
19. Administration of dazoxiben, a selective thromboxane synthetase inhibitor, in the adult respiratory distress syndrome.
Leeman M; Boeynaems JM; Degaute JP; Vincent JL; Kahn RJ
Chest; 1985 Jun; 87(6):726-30. PubMed ID: 4039645
[TBL] [Abstract][Full Text] [Related]
20. Thromboxane generation after thrombin. Protective effect of thromboxane synthetase inhibition on lung fluid balance.
Garcia-Szabo RR; Peterson MB; Watkins WD; Bizios R; Kong DL; Malik AB
Circ Res; 1983 Aug; 53(2):214-22. PubMed ID: 6684001
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
